TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc.
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$7.00 | 49,000 | 1,902,659 | 2024-02-13 | Filing | ||
$7.00 | 40,000 | 1,365,646 | 2024-02-13 | Filing | ||
$7.00 | 49,000 | 5,455,431 | 2024-02-13 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.20 | 200 | Officer, Director | 29,600 | 2024-08-19 | Filing | |
$6.01 | 200 | Officer, Director | 29,600 | 2024-08-19 | Filing |